CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 37 filers reported holding CUE BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,840,510 | $5,245,454 | 2.86% |
| P.A.W. CAPITAL CORP | 180,000 | $513,000 | 1.40% |
| Bleichroeder LP | 861,278 | $2,454,642 | 0.53% |
| Monaco Asset Management SAM | 497,177 | $1,416,954 | 0.43% |
| Slate Path Capital LP | 2,402,455 | $6,846,997 | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 306,278 | $872,892 | 0.25% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,363,725 | 0.13% |
| CARLSON CAPITAL L P | 365,000 | $1,040,250 | 0.08% |
| Voss Capital, LLC | 125,000 | $356,250 | 0.07% |
| ADVISORY RESEARCH INC | 257,225 | $733,091 | 0.07% |